Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
57. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999: 728—734.
58. Menon S, Jameson-Shortall E, Newman SP, Hall-Craggs MR, Chinn R, Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 735—741.
59. Asherson RA, Mercey D, Phillips G et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1987; 46: 605—611.
SHS-OOO4.qxd 21.11.2006 16:56 Page 197
ГЛАВА 7. Клинические проявления антифосфолипидного синдрома
60. Montalban J, Fernandez J, Arderiu A et al. Multi-infarct dementia associated with antiphos-pholipid antibodies. Presentation of two cases. Med Clin (Barc) 1989; 93: 424—426.
61. Kurita A, Hasunuma T, Mochio S, Shimada T, Isogai Y, Kurahashi T. A young case with multi-infarct dementia associated with lupus anticoagulant. Intern Med 1994; 33: 373—375.
62. Westerman EM, Miles JM, Backonja M, Sundstrom WR. Neuropathologic findings in multi-infarct dementia associated with anticardi-olipin antibody. Evidence for endothelial injury as the primary event. Arthritis Rheum 1992; 35: 1038—1041.
63. Agrawal BL, Foa RP. Collagen vascular disease appearing as chorea gravidarum. Arch Neurol 1982; 39: 92—193.
64. Herd JK, Medhi M, Uzendoski DM, Sal-divar VA. Chorea associated with systemic lupus erythematosus: report of two cases and review of the literature. Pediatrics 1978; 61: 308—315.
65. Asherson RA, Hughes GRV. Antiphos-pholipid antibodies and chorea. J Rheumatol 1988; 15: 377—9.
66. Cervera R, Asherson RA, Font J et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997; 7 6: 203—12.
67. Scott TF, Hess D, Brillman J. Antiphos-pholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging. Arch Intern Med 1994; 154: 917—920.
68. Tourbah A, Clapin A, Gout O et al. Systemic autoimmune features and multiple sclerosis: a 5year follow-up study. Arch Neurol 1998; 55: 517—521.
69. Karussis D, Leker RR, Ashkenazi A, Ab-ramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998; 44: 629— 634.
70. Roussel V, Yi F, Jauberteau MO et al. Prevalence and clinical significance of anti-phospho-lipid antibodies in multiple sclerosis: a study of 89 patients. JAutoimmun 2000; 14: 259—265.
71. Sastre-Garriga J, Reverter JC, Font J, Tintore M, Espinosa G, Montalban X. Anticar-
diolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Ann Neurol 2001; 49: 408—411.
72. Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, Derue G, Hughes GRV. Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies. Ann Rheum Dis 1985; 44: 281—283.
73. Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990; 17: 34—37.
74. Ruiz-Arguelles GJ, Guzman-Ramos J, Flores-Flores J, Garay-Martinez J. Refractory hiccough heralding transverse myelitis in the primary antiphospholipid syndrome. Lupus 1998; 7: 49—50.
75. Kovacs B, Lafferty TL, Brent LH, DeHora-tius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000; 59:120— 124.
76. Sussman J, Leach M, Greaves M, Malia R, Davies-Jones GA. Potentially prothrombotic abnormalities of coagulation in benign intracra-nial hypertension. J Neurol Neurosurg Psychiatry 1997; 62:229—33.
77. Leker RR, Steiner I. Anticardiolipin antibodies are frequently present in patients with idio-pathic intracranial hypertension. Arch Neurol 1998; 55: 817—820.
78. Kesler A, Ellis MH, Reshef T, Kott E, Ga-doth N. Idiopathic intracranial hypertension and anticardiolipin antibodies. J Neurol Neurosurg Psychiatry 2000; 68: 379—380.
79. Hisashi K, Komune S, Taira T, Uemura T, Sadoshima S, Tsuda H. Anticardiolipin antibody-induced sudden profound sensorineural hearing loss. Am J Otolaryngol 1993;14: 275—277.
80. Casoli P, Tumiati B. Cogan's syndrome: a new possible complication of antiphospholipid antibodies? Clin Rheumatol 1995; 14:197—198.
81. Toubi E, Ben-David J, Kessel A, Podoshin L, Golan TD. Autoimmune aberration in sudden sensorineural hearing loss: association with anti-cardiolipin antibodies. Lupus 1997; 6: 540—2.
82. Naarendorp M, Spiera H. Sudden sen-sorineural hearing loss in patients with systemic
SHS-OOO4.qxd 21.11.2006 16:56 Page 198
Насонов Е.Л. Антифосфолипидный синдром.
lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies. J Rheumatol 1998; 25: 589—92.
